0.5769

9.85% -0.063

Aspira Womens Health Inc (AWH)

Overview News Price History Financials Discussions Forecast Stock Split

Aspira Womens Health Inc stock is traded at $0.5769, with a volume of 55,237. It is down -9.85% in the last 24 hours and down -23.06% over the past month. Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.

Previous Close:

$0.6399

Open:

$0.6207

24h Volume:

55,237

Relative Volume:

0.55

Market Cap:

$9.62M

Revenue:

$9.15M

Net Income/Loss:

$-16.18M

P/E Ratio:

-0.3278

EPS:

-1.76

Net Cash Flow:

$-15.92M

1W Performance:

-23.08%

1M Performance:

-23.06%

6M Performance:

-64.17%

1Y Performance:

-88.23%

1-Day Range:

$0.5701

$0.6207

1-Week Range:

$0.5701

$0.75

52-Week Range:

$0.5701

$5.65

Aspira Womens Health Inc Stock (AWH) Company Profile

Name

Aspira Womens Health Inc

Sector

Healthcare (1191)

Industry

Diagnostics & Research (58)

Phone

512-519-0400

Address

12117 BEE CAVES ROAD BUILDING THREE, AUSTIN

Employee

Twitter

@ASPiRALabs

Next Earnings Date

2024-12-13

Latest SEC Filings

AWH's Discussions on Twitter

Compare AWH with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
AWH Aspira Womens Health Inc	0.5769	9.62M	9.15M	-16.18M	-15.92M	-1.76
TMO Thermo Fisher Scientific Inc	556.99	213.05B	42.37B	6.14B	7.78B	15.95
DHR Danaher Corp	237.62	171.63B	23.74B	3.89B	4.98B	5.24
A Agilent Technologies Inc	143.43	40.54B	6.51B	1.29B	1.37B	4.42
IQV Iqvia Holdings Inc	197.96	35.93B	15.32B	1.41B	1.96B	7.62
IDXX Idexx Laboratories Inc	418.63	34.28B	3.84B	866.24M	792.60M	10.37

Aspira Womens Health Inc Stock (AWH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-12-22	Resumed	Cantor Fitzgerald	Overweight
Mar-29-21	Initiated	Truist	Buy
Jan-29-21	Initiated	Cantor Fitzgerald	Overweight
Oct-30-20	Initiated	William Blair	Outperform

Aspira Womens Health Inc Stock (AWH) Latest News

Jan 12, 2025

Bioxytran (OTCMKTS:BIXT) to Release Cancer Preprint Revealing Potential Immunotherapy EnhancementOn January 10, 2025, Bioxytran Inc., a clinical-stage biotechnology company focused on developing oral and intravenous drugs for various conditions, a - Defense World

Jan 12, 2025

Aspira Women’s Health (NASDAQ:AWH) Now Covered by Analysts at StockNews.com - Defense World

Jan 12, 2025

Jan 10, 2025

Aspira Women’s Health Appoints Mike Buhle as SVP of Commercial Operations - citybiz

Jan 10, 2025

Aspira Women's Health Inc. Appoints Mike Buhle as SVP of Commercial Operations - Marketscreener.com

Jan 10, 2025

Aspira Women's Health Announces the Appointment of Mike Buhle as SVP of Commercial Operations - AccessWire

Jan 10, 2025

Jan 07, 2025

Aspira Women’s Health (NASDAQ:AWH) Coverage Initiated at StockNews.com - Defense World

Dec 31, 2024

Dec 27, 2024

Aspira Women's Health in Shelton to use $10M grant to create blood test to detect endometriosis - CTPost

Dec 27, 2024

Dec 25, 2024

Aspira Women’s Health (NASDAQ:AWH) Earns Hold Rating from Analysts at StockNews.com - Defense World

Dec 25, 2024

Organon & Co. (NYSE: OGN) Reduces Board Size Following Resignation of Director - Defense World

Dec 25, 2024

Dec 17, 2024

Aspira Women's Health's SWOT analysis: stock outlook amid diagnostic growth - Investing.com Nigeria

Dec 17, 2024

Aspira Women's Health CEO steps down, interim appointed By Investing.com - Investing.com Canada

Dec 17, 2024

Dec 16, 2024

Aspira Women’s Health CEO Transition and Leadership Change - TipRanks

Dec 16, 2024

AWHAspira Women's Health Inc. Latest Stock News & Market Updates - StockTitan

Dec 16, 2024

Akari Therapeutics Appoints Torsten Hombeck, Ph.D. as Chief Financial Officer - citybiz

Dec 16, 2024

Aspira Women’s Health Appoints Dr. Sandra Milligan as Interim CEO - citybiz

Dec 16, 2024

Akari Therapeutics Strengthens Leadership: Former CFO Returns After $50M Fundraising Success - StockTitan

Dec 16, 2024

Aspira Women's Health Announces Appointment of Dr. Sandra Milligan as Interim CEO - The Manila Times

Dec 16, 2024

Aspira Women's Health CEO Steps Down Following OvaWatch Launch, $10M Research Grant Success - StockTitan

Dec 16, 2024

Dec 13, 2024

StockNews.com Begins Coverage on Aspira Women’s Health (NASDAQ:AWH) - Defense World

Dec 13, 2024

Dec 11, 2024

Aspira Women's Health's SWOT analysis: stock faces growth potential amid financial hurdles - Investing.com Nigeria

Dec 11, 2024

Dec 05, 2024

CURE® SURVEY UNVEILS WHAT INVESTORS LOOK FOR IN FUNDING WOMEN'S HEALTH - PR Newswire

Dec 05, 2024

Dec 03, 2024

AWS supports ARPA-H Sprint for Women’s Health to advance crucial research and solutions - AWS Blog

Dec 03, 2024

Aspira Women's Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award - The Manila Times

Dec 03, 2024

Aspira Women's Health Secures $2M ARPA-H Grant for AI-Powered Endometriosis Test - StockTitan

Dec 03, 2024

Dec 01, 2024

StockNews.com Initiates Coverage on Aspira Women’s Health (NASDAQ:AWH) - Defense World

Dec 01, 2024

Nov 20, 2024

Aspira: Q3 Earnings Snapshot - New Haven Register

Nov 20, 2024

Nov 19, 2024